The risk of death from kidney cancer has decreased in the United States in recent years, but the risk varies by sex, race, and ethnicity, according to research published in The Oncologist.

Adding an immune checkpoint inhibitor to neoadjuvant chemotherapy can improve pathologic complete response rates and may improve survival in patients with muscle-invasive bladder cancer, research ...

Two studies examining relationships between measures of kidney function and adverse events after platinum-based chemotherapy were presented as late-breaking abstracts at the National Kidney Foundation ...

Having a larger brain tumor at diagnosis is associated with a higher risk of death, longer hospital stays, and greater neurological deficits, a study suggests.

The FDA has issued a complete response letter to Telix Pharmaceuticals regarding TLX101-CDx for the imaging of gliomas.

In reducing federal funding and downsizing federal health agencies, the Trump administration is impeding cancer research.

The primary endpoint was the mean normalcy of diet score on the clinician-rated Performance Status Scale for Head and Neck at 1 year. The mean score was 91.6 in the dose-reduction arm and 92.6 in the ...